Switch to:
More From Other Websites
Pfizer’s Dollar Dilemma Adds Pressure for Deal Making Jul 28 2015
Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal Jul 28 2015
Gilead higher after earnings beat Jul 28 2015
Broad rally in the market Jul 28 2015
Pfizer Quits Over-the-Counter Lipitor Program After Trial Fails Jul 28 2015
Edited Transcript of PFE earnings conference call or presentation 28-Jul-15 2:00pm GMT Jul 28 2015
Pfizer chief executive has 'sufficient courage' to pursue deals Jul 28 2015
Pfizer Eyeing Deals of Any Size in Quest to Find New Blockbuster Jul 28 2015
Pfizer Beats Estimates On Strong Cancer Drug Sales Jul 28 2015
Pfizer Boosts Its Earnings Outlook Jul 28 2015
Drugmaker Pfizer tops Street 2Q forecasts, raises forecast Jul 28 2015
Drugmaker Pfizer tops Street 2Q forecasts, raises forecast Jul 28 2015
Pfizer's revenue, profit beat as vaccine sales rise Jul 28 2015
Pfizer's revenue, profit beat as vaccine sales rise Jul 28 2015
Pfizer's revenue, profit beat as vaccine sales rise Jul 28 2015
Stocks attempt bounce as Fed meeting begins Jul 28 2015
Pfizer (PFE) Stock Climbs on Strong Earnings Jul 28 2015
Pfizer earnings fall 10% on lower revenue, foreign exchange losses Jul 28 2015
Pfizer Beats on Q2 Earnings and Revenues, Revises Outlook - Analyst Blog Jul 28 2015
Pfizer beats, Dupont warns; UPS hurt by dollar; Ford soars Jul 28 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

SEENSCO
ReplySEENSCO - 1 year ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK